Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study

被引：0
|
作者：
Seoyoung C. Kim
Robert J. Glynn
Jun Liu
Brendan M. Everett
Allison B. Goldfine
机构：
[1] Brigham and Women’s Hospital,Division of Pharmacoepidemiology and Pharmacoeconomics
[2] Brigham and Women’s Hospital,Division of Rheumatology, Allergy and Immunology
[3] Brigham and Women’s Hospital,Division of Cardiovascular Medicine
[4] Joslin Diabetes Center,Clinical Research
来源：
Acta Diabetologica | 2014年 / 51卷
关键词：
Dipeptidyl peptidase-4 inhibitor; Type 2 diabetes; Cardiovascular disease; Heart failure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1023
页数：8
相关论文
共 50 条
  • [1] Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study
    Kim, Seoyoung C.
    Glynn, Robert J.
    Liu, Jun
    Everett, Brendan M.
    Goldfine, Allison B.
    ACTA DIABETOLOGICA, 2014, 51 (06) : 1015 - 1023
  • [2] Dipeptidyl Peptidase-4 Inhibitors Do Not Increase the Risk of Cardiovascular Events in Type 2 Diabetes
    Kim, Seoyoung C.
    Glynn, Robert
    Liu, Jun
    Everett, Brendan
    Goldfine, Allison
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 188 - 189
  • [3] Dipeptidyl Peptidase-4 Inhibitors Do Not Increase the Risk of Cardiovascular Events in Type 2 Diabetes: A Population-Based Cohort Study
    Kim, Seoyoung C.
    Glynn, Robert
    Liu, Jun
    Everett, Brendan M.
    Goldfine, Allison B.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [4] In type 2 diabetes, dipeptidyl peptidase-4 inhibitors do not increase pancreatitis
    Morey-Vargas, Oscar L.
    Montori, Victor M.
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (02)
  • [5] Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes
    Chatterjee, Saurav
    Chatterjee, Sanjay
    ANNALS OF INTERNAL MEDICINE, 2013, 158 (08)
  • [6] Do Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure in Patients with Type 2 Diabetes?
    Hassanabad, Mortaza Fatehi
    Hassanabad, Ali Fatehi
    Fatehi, Mohammad
    CURRENT DIABETES REVIEWS, 2022, 18 (08)
  • [7] Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease
    Baksh, Sheriza N.
    Segal, Jodi B.
    McAdams-DeMarco, Mara
    Kalyani, Rita R.
    Alexander, G. Caleb
    Ehrhardt, Stephan
    PLOS ONE, 2020, 15 (10):
  • [8] The Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus: Cardiovascular Safety
    Green, Jennifer B.
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 54 - 61
  • [9] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes
    Koska, Juraj
    Sands, Michelle
    Burciu, Camelia
    Reaven, Peter
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (03): : 154 - 163
  • [10] Do Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure?
    Bhatt, Deepak L.
    Cavender, Matthew A.
    JACC-HEART FAILURE, 2014, 2 (06) : 583 - 585
12345